COVID-19: ICMR, Biological E develop ‘Antisera’ for virus cure, prevention
First Published: 2nd October, 2020 15:48 IST
As part of the global attempt to find a remedy for coronavirus, the Indian Council of Medical Research (ICMR) and Biological E Limited, Hyderabad have developed highly purified antisera (raised
As part of the global attempt to find a remedy for coronavirus, the Indian Council of Medical Research (ICMR) and Biological E Limited, Hyderabad have developed highly purified antisera (raised in animals) for prophylaxis and treatment of the infectious disease.
“ICMR and Biological E Limited, Hyderabad have developed highly purified antisera (raised in animals) for prophylaxis and treatment of COVID-19,” the ICMR tweeted on Thursday.
Biological E Limited is one among the listed entities, which have been allowed by the Central Drugs Standard Control Organisation (CDSCO) to manufacture the vaccines for limited use.
The top medical body said that such measures have previously been used in medical science to control many viral and bacterial infections such as Rabies, Hepatitis B, Vaccinia virus, Tetanus, Botulism and Diphtheria.
“Although plasma recovered from patients experiencing COVID-19 could serve a similar purpose, the profile of antibodies, their efficacy, and concentration keep varying from one patient to another and therefore make it an unreliable clinical tool for patient management,” the ICMR said.
It added that the standardization achievable through equine sera based treatment modality thus stood out as another remarkable public health initiative supported by ICMR in the time of COVID-19. (ANI)
COMMENTS
TOPMOST STORY NOW
Live Vishal Kumar, Returning Officer for West Tripura LS seat briefs media
19th April 2024Live Nagaland Chief Electoral Officer briefs media after voting officially ends
19th April 2024Live Lok Sabha Polls: Meghalaya CEO BDR Tiwari briefs media
19th April 2024Live Indefinite shutdown and poll boycott in Eastern Nagaland: ENPO president speaks to Northeast Live
19th April 2024WE RECOMMEND
High turnout in Phase 1 of Lok Sabha Elections 2024 despite heat wave
The Commission led by CEC Rajiv Kumar and ECs Gyanesh Kumar and Sukhbir Singh Sandhu constantly monitored the progress of polling in Phase 1 across the constituencies from ECI Headquarters in Nirvachan Sadan.
19th April 2024Lok Sabha elections 2024 Phase 1: Big faces and high-stakes battles
The candidature of its Tamil Nadu state president shows that the BJP is pressing hard to increase its presence in South India
19th April 2024“You are not innocent”: SC tells Ramdev, he says will remain conscious in future
Co-founder of Patanjali Ayurved Ltd., Ramdev, tendered unconditional apology "for the mistakes", adding that "What we did at the time was not correct. We will be conscious about it in the future."
16th April 2024Need skills to go far beyond Earth’s orbit: ISRO chief Somanath at Inter-Agency Space Debris Coordination Committee
The ISRO chief also issued a declaration saying that India aims to create debris free space missions by 2030.
16th April 2024Five killed, several injured as bus falls from flyover in Odisha’s Jajpur
Chief District Medical Officer (CDMO) Shibasish Moharana said that out of 38 injured, one was seriously injured.
16th April 2024